Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Quick Ratio is 0.23 as of Feb. 2026, which is 21% below its 10-year median of 0.29. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 680 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 93.97% on this metric.
COSMOS Pharmaceutical has a quick ratio of 0.23. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for COSMOS Pharmaceutical's Quick Ratio or its related term are showing as below:
CSMYF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.29 Max: 0.4
Current: 0.23
During the past 13 years, COSMOS Pharmaceutical's highest Quick Ratio was 0.40. The lowest was 0.17. And the median was 0.29.
CSMYF's Quick Ratio is ranked worse than 93.97% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.32
vs CSMYF: 0.23
COSMOS Pharmaceutical (OTCPK:CSMYF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
COSMOS Pharmaceutical Quick Ratio Related Terms
COSMOS Pharmaceutical Quick Ratio Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Quick Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Quick Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Quick Ratio distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
COSMOS Pharmaceutical's Quick Ratio for the fiscal year that ended in May. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Quick Ratio of 0.23 as of Feb. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on COSMOS Pharmaceutical and its competitors. This is 21% below median its historical median of 0.29. Over the past decade, COSMOS Pharmaceutical's Quick Ratio has ranged from 0.17 to 0.40. According to the industry distribution chart, COSMOS Pharmaceutical ranks #639 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 94%.
Is COSMOS Pharmaceutical's Quick Ratio too high?
COSMOS Pharmaceutical's current Quick Ratio of 0.23 is 21% below median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.40. The Healthcare Providers & Services industry median Quick Ratio is 1.32. COSMOS Pharmaceutical's value of 0.23 is 82.6% below this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #639 out of 680 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Quick Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #639 out of 680 companies for Quick Ratio. This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Quick Ratio is 1.32. COSMOS Pharmaceutical's value of 0.23 is 82.6% below this benchmark. Historically, COSMOS Pharmaceutical's own Quick Ratio has ranged from 0.17 to 0.40 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 1.32, COSMOS Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Quick Ratio of 0.23 is 82.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Quick Ratio is 0.23, which is 21% below median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Quick Ratio is 0.23, which is 21% below median its 10-year median of 0.29 and 82.6% below the Healthcare Providers & Services industry median of 1.32. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Quick Ratio is 0.23 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Quick Ratio: 0.23 (21% below median its 10-year median of 0.29)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 82.6% below the Healthcare Providers & Services median (#639 of 680)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
